Immunotherapy agent

PD-1/PD-L1 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immunotherapy agent, covering 2025-10-01 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer [Phase 2]